Alivus Life

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE03Q201024
  • NSEID: ALIVUS
  • BSEID: 543322
INR
880.95
10.35 (1.19%)
BSENSE

Dec 05

BSE+NSE Vol: 1.21 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAlivus Life VS Pharmaceuticals & Biotechnology
 
1D
1.19%
0.36%
1W
-1.71%
-0.16%
1M
-2.73%
2.53%
YTD
-10.93%
9.51%
1Y
-18.34%
4.66%
3Y
102.03%
36.19%
5Y
%
89.83%
10Y
%
233.77%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.58%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.97%
0%
-4.97%
6 Months
-13.3%
0.49%
-12.81%
1 Year
-18.34%
0.48%
-17.86%
2 Years
38.61%
0.78%
39.39%
3 Years
102.03%
11.38%
113.41%
4 Years
45.84%
9.92%
55.76%
5 Years
0%
0%
0.0%

Latest dividend: 5 per share ex-dividend date: Sep-01-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Alivus Life Sciences Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-6.32%
2
Quartile
quartile-2
Jun-Sep
-8.19%
4
Quartile
quartile-4
Mar-Jun
-6.24%
3
Quartile
quartile-3
YTD
-19.3%
3
Quartile
quartile-3
2024
50.51%
2
Quartile
quartile-2
2023
56.28%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Good Performer

Alivus Life Sciences Ltd has been in the First and Second Quartile in the YTD and longer periods

3
Quartile
quartile-3
QTD
-6.32%
3
Quartile
quartile-3
Jun-Sep
-8.19%
4
Quartile
quartile-4
Mar-Jun
-6.24%
2
Quartile
quartile-2
YTD
-19.3%
2
Quartile
quartile-2
2024
50.51%
2
Quartile
quartile-2
2023
56.28%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Alivus Life Sciences Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-6.32%
3
Quartile
quartile-3
Jun-Sep
-8.19%
4
Quartile
quartile-4
Mar-Jun
-6.24%
3
Quartile
quartile-3
YTD
-19.3%
2
Quartile
quartile-2
2024
50.51%
2
Quartile
quartile-2
2023
56.28%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available